Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.

MLA

Nuttall, M. E., et al. “Idoxifene: A Novel Selective Estrogen Receptor Modulator Prevents Bone Loss and Lowers Cholesterol Levels in Ovariectomized Rats and Decreases Uterine Weight in Intact Rats.” Endocrinology, vol. 139, no. 12, Dec. 1998, pp. 5224–34. EBSCOhost, https://doi.org/10.1210/endo.139.12.6343.

APA

Nuttall, M. E., Bradbeer, J. N., Stroup, G. B., Nadeau, D. P., Hoffman, S. J., Zhao, H., Rehm, S., & Gowen, M. (1998). Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology, 139(12), 5224–5234. https://doi.org/10.1210/endo.139.12.6343

Chicago

Nuttall, M E, J N Bradbeer, G B Stroup, D P Nadeau, S J Hoffman, H Zhao, S Rehm, and M Gowen. 1998. “Idoxifene: A Novel Selective Estrogen Receptor Modulator Prevents Bone Loss and Lowers Cholesterol Levels in Ovariectomized Rats and Decreases Uterine Weight in Intact Rats.” Endocrinology 139 (12): 5224–34. doi:10.1210/endo.139.12.6343.